Opko Health CEO Purchases $638,994 in Stock (OPK)
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 75,800 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were purchased at an average cost of $8.43 per share, for a total transaction of $638,994.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $16,754,625. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Opko Health (NYSE:OPK) traded down 0.41% during mid-day trading on Thursday, hitting $8.405. The stock had a trading volume of 2,197,528 shares. Opko Health has a 1-year low of $4.83 and a 1-year high of $12.95. The stock’s 50-day moving average is $9.77 and its 200-day moving average is $8.91. The company’s market cap is $3.429 billion.
Several analysts have recently commented on the stock. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.